Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.25p -6.92% 30.25p 30.00p 30.50p 32.50p 29.75p 32.50p 1,586,942 16:29:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 62.00

Futura Medical PLC Block listing update

30/11/2018 8:54am

UK Regulatory (RNS & others)

Futura Medical (LSE:FUM)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more Futura Medical Charts.


RNS Number : 0387J

Futura Medical PLC

30 November 2018

Block Listing Update

30 November 2018

Futura Medical plc (AIM: FUM) (the "Company"), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares of 0.2 pence each (Ordinary Shares).

The table below provides further detail. The figures include the block admission of 1,765,000 Ordinary Shares earlier today, as announced on 26 November 2018.

  Name of company:                    Futura Medical plc 
  Name of scheme(s):                  Unapproved Share Option Scheme ("USOS") 
                                       Unapproved Share Incentive Scheme ("USIS") 
                                       EMI Share Option Scheme ("EMI") 
  Period of return:                   From:                           31 May 2018 
                                      To:                             30 November 2018 
                                        USOS:                           2,343,965 
                                      USIS:                           - 
                                      EMI:                            2,843,535 
  Number and class of securities 
   not issued under the scheme(s) 
   at beginning of period             Total:                          5,187,500 
                                    ------------------------------  ------------------------------ 
  Number and class of securities      USOS:                           - 
  admitted to the scheme(s) in the 
                                      USIS:                           425,000 
                                      EMI:                            1,340,000 
                                      Total:                          1,765,000 
                                    ------------------------------  ------------------------------ 
  Number of securities issued         USOS:                           - 
  under the scheme(s) during the 
                                      USIS:                           - 
                                      EMI:                            - 
                                      Total:                          - 
                                    ------------------------------  ------------------------------ 
  Number of securities lapsed 
   under the scheme(s) during the 
   period                             USOS:                           350,090 
                                      USIS:                           - 
                                      EMI:                            377,410 
                                      Total:                          727,500 
                                    ------------------------------  ------------------------------ 
  Balance of securities under the 
   scheme(s) not yet issued at the 
   end of the period                  USOS:                           1,993,875 
                                      USIS:                           425,000 
                                      EMI:                            3,806,125 
                                      Total:                          6,225,000 
                                    ------------------------------  ------------------------------ 
  Number and class of securities      USOS:                              814,424      25 May 2011, 
  originally admitted and the date                                        1,202,280    8 October 
  of admission                                                                          2013, 
                                                                          1,466,208    25 May 2017, 
                                                                          400,000      30 May 2018, 
                                      USOS Total:                      3,882,912 
                                    ------------------------------  ------------------------------ 
                                       USIS:                            425,000    30 November 
                                      USIS Total:                     425,000 
                                    ------------------------------  ------------------------------ 
                                      EMI:                              1,520,576    25 May 2011, 
                                                                        1,467,720    8 October 
                                                                        1,893,792    25 May 2017, 
                                                                        790,000      30 May 2018, 
                                                                        1,340,000    30 November 
                                      EMI Total:                      7,012,088 
                                    ------------------------------  ------------------------------ 
                                      Total:                          11,320,000 
                                    ------------------------------  ------------------------------ 
  Name of contact:                    Angela Hildreth, Finance Director/Chief Operating Officer 
  Telephone number of contact:        +44 (0) 1483 685 670 

For further information please contact:

Futura Medical plc

James Barder, Chief Executive

Angela Hildreth, Finance Director and COO


Tel: +44 (0) 1483 685 670

Nominated Adviser and Broker:

N+1 Singer

Aubrey Powell/ Ben Farrow (Corporate Finance)

Tom Salvesen/ Mia Gardner (Corporate Broking)

Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Optimum Strategic Communications

Mary Clark/ Hollie Vile/ Ellie Blackwell


Tel: +44 (0) 203 950 9144

Notes to editors

About Futura Medical plc

Futura Medical plc (AIM: FUM), is a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys(R) drug delivery technology. These products are optimised for clinical efficacy, safety, administration and patient convenience and are developed for the prescription and consumer healthcare markets as appropriate. Current therapeutic areas are sexual health, including erectile dysfunction, and pain relief. Development and commercialisation strategies are designed to maximise product differentiation and value creation whilst minimising risk.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

November 30, 2018 03:54 ET (08:54 GMT)

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart
Your Recent History
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190625 05:23:29